Subject: SCV Client's MJTV and PZOO Featured on MoneyTV PZOO Issues Update on Activities

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
SCV Client's MJTV and PZOO Featured on MoneyTV PZOO Issues Update on Activities
Hot Stock to WatchHot Stock to Watch

Company: Pazoo, Inc. (Pink Sheets: PZOOD)


Price: 0.035

Change (%): + 0.0095 (37.25)

Volume: 40,008
PZOO Chart

MoneyTV with Donald Baillargeon, 5/5

LOS ANGELES, CA / ACCESSWIRE / May 5, 2017 / Cloud computing, cannabis testing, cannabis payments, solar power storage, financial victims, credit repair, female sensual arousal, goodbye Hillary Clinton; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (, featuring informative interviews with company CEOs, providing insights into their operations and outlooks for their futures.

Featured companies on this week's program include:

Michael James Enterprises, Inc. (MJTV) CEO James Farinella spoke of new product packaging and a financing deal.

Pazoo, Inc. (OTC PINK: PZOO) David Cunic discussed progress at their marijuana testing labs.

Continue Reading

Pazoo, Inc. CEO Speaks at Cannabis Convention and Subsidiary MA & Associates, LLC Continues Processing Samples

FLORHAM PARK, N.J., May 2, 2017 /PRNewswire/ - Pazoo, Inc. (OTC Pinks: PZOO) is pleased to announce that its subsidiary, MA & Associates, LLC (MA), a cannabis testing lab in Las Vegas has continued to process mock samples, making the necessary adjustments in extraction methods for the different kinds of cannabis products. Their chromatography methods are working and they are ensuring the extraction methods yield consistent results in complex cannabis products. So far, the lab has processed four types of edibles, oils, and lotion for the first level of samples which will be processed for actual customers. This week the lab will be starting on wax, additional edibles and other products.

Furthermore, last week on April 22 and 23, the CEO of Pazoo, David Cunic, was a guest speaker at the annual New England Cannabis Convention (NECANN) and was part of the Cannabis Investment & Entrepreneur Panel of Experts at NECANN in Boston, Massachusetts. David offered his forecast on the trajectory of the booming cannabis industry and specifically, the testing lab sector. David also addressed a key issue of varying cannabis regulations. He provided his take on the importance of establishing consistent nationwide cannabis testing requirements to a sold-out room. By combining an efficient and cost-effective methodology, the MA team can perform the most accurate and efficient testing that is available on the market.

“Everyone at Pazoo and MA & Associates, LLC takes pride in following the stringent cannabis laboratory testing guidelines, established by the state of Nevada, to ensure every sample test is evaluated carefully so we can provide the most accurate results”, said David Cunic, CEO Pazoo. “Cannabis is a medicine, and must be used safely. It’s important that with each prescription, patients are aware of the potency so they can better select a mixture that will offer the best medical benefits for their health. With every sample, we carefully examine potency and harmful impurities, such as mold, fungus, pesticides, and more even before the product is sold at legal dispensaries in states where medical marijuana is approved.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks